Clinical outcomes and predictors of mortality in COVID-19 patients admitted to a High Dependency Unit in Pakistan-a cross-sectional study

Objective: To determine the outcomes and predictors of in-hospital mortality of patients admitted to high-dependency unit with coronavirus disease 2019 infection. Method: The retrospective study was conducted at a tertiary care hospital in Karachi, and comprised data of adult coronavirus disease 2019 patients of either gender admitted to the high dependency unit from March 1 to June 30, 2020. Outcomes were categorised as patients ‘recovered without deterioration’, ‘deteriorated but survived’, and ‘deteriorated but expired’. Data was analysed using SPSS 22. Results: Of the 525 patients with confirmed infection, 245(46.6%) were admitted to the high dependency unit. Leaving out 38(15.5%) cases with missing data, 207(84.5%) cases formed the study sample; 156(75.4%) males and 51(24.6%) females. The overall mean age was 56.9±14years (range: 24-86 years). The most common comorbid condition was hypertension 105(50.7%), and the most common reason for critical care was hypoxic respiratory failure 199(96.1%). Of the total, 153(74%) patients recovered, 31(15%) deteriorated, and mortality was the outcome in 23(11%). There was no significant effect of drug treatment on mortality (p>0.05). Age, multimorbidity and high D-Dimer level were significantly associated with disease progression and mortality (p<0.05). Conclusion: Mortality was high among coronavirus disease 2019 patients who were older and had multimorbidity. Key Words: COVID-19, In-hospital mortality, Multimorbidity, SARS-CoV-2 infection, Critical care outcomes.

[1]  M. Mantero,et al.  COVID-19 multidisciplinary high dependency unit: the Milan model , 2020, Respiratory Research.

[2]  D. Pestaña,et al.  Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome , 2020, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[3]  L. Brammer,et al.  Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Zhe Luo,et al.  D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study , 2020, Journal of Intensive Care.

[5]  C. Macaya,et al.  Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry , 2020, Journal of Nephrology.

[6]  J. Phua,et al.  Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature , 2020, Critical Care.

[7]  R. Pranata,et al.  Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis , 2020, Postgraduate Medical Journal.

[8]  Amit N. Patel,et al.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.

[9]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[10]  Yuan Yu,et al.  Thrombocytopenia and its association with mortality in patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[11]  Fang Liu,et al.  Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 , 2020, Journal of Clinical Virology.

[12]  M. Haghighi,et al.  Review of therapeutic agents for the treatment of COVID-19 , 2020 .

[13]  S. Merler,et al.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.

[14]  T. Prata,et al.  What do we know about COVID-19? A review article. , 2020, Revista da Associacao Medica Brasileira.

[15]  M. Cascella,et al.  Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .

[16]  Sharukh Lokhandwala,et al.  Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.

[17]  Srinivas Murthy,et al.  Care for Critically Ill Patients With COVID-19. , 2020, JAMA.

[18]  Mario Plebani,et al.  Laboratory abnormalities in patients with COVID-2019 infection , 2020, Clinical chemistry and laboratory medicine.

[19]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[20]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[21]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[22]  D. Prytherch,et al.  A Comparison of the Quick Sequential (Sepsis-Related) Organ Failure Assessment Score and the National Early Warning Score in Non-ICU Patients With/Without Infection , 2018, Critical care medicine.

[23]  edited and reported by Inamul Haq Medicinal plants: report of Committee on Economic and Therapeutic Importance of Medicinal Plants initiated by the Ministry of Health, Government of Pakistan , 2016 .

[24]  C. O'connor,et al.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. , 2004, Journal of the American College of Cardiology.

[25]  Muddassir Malik,et al.  Pakistan , 2002 .